MentalHealthDaily

Copy Number Variants Did Not Moderate ADHD or Autism Outcomes in ALSPAC

by GLOOM

Photoreal illustration of DNA strands and developmental timeline overlaid on a schematic young adult, conveying genetic moderation of childhood neurodevelopmental outcomes.

A 2026 ALSPAC analysis tested a narrow claim behind routine genetic screening for childhood attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD): whether rare copy number variants (CNVs; deleted or duplicated DNA segments) make young-adult outcomes worse than ADHD/ASD status alone would predict. In 8,414 people with usable CNV data, ADHD and ASD predicted worse …

GeneSight: Genetic Test Predicts Best & Worst Antidepressants for Each Person

by GLOOM

It’s no secret that depression is becoming one of the biggest epidemics in the United States and throughout the world. Many people suffer from mental illnesses, but depression is a condition that seems to affect everyone at some point in their lives. Unfortunately there is no pill that will cure depression, but there are various …